Daiwa Securities Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$618K Buy
7,172
+575
+9% +$51.6K ﹤0.01% 866
2025
Q4
$576K Buy
6,597
+275
+4% +$20.9K ﹤0.01% 860
2025
Q3
$362K Buy
6,322
+1,271
+25% +$73.2K ﹤0.01% 925
2025
Q2
$298K Buy
5,051
+3,819
+310% +$247K ﹤0.01% 919
2025
Q1
$90K Buy
+1,232
New +$102K ﹤0.01% 974
2024
Q2
Sell
-9,300
Closed -$499K 1339
2024
Q1
$499K Hold
9,300
﹤0.01% 839
2023
Q4
$496K Hold
9,300
﹤0.01% 831
2023
Q3
$462K Buy
+9,300
New +$520K ﹤0.01% 842

Other funds holding GMED

Daiwa Securities Group's GMED Position: Q1 2026 in Review

Daiwa Securities Group increased its Globus Medical (GMED) stake by 8.7% in Q1 2026, buying an estimated $51.6K and bringing the position to 7,172 shares worth $618K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Daiwa Securities Group first reported a position in GMED in Q3 2023 and has held it in 8 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Daiwa Securities Group held 7,172 shares of Globus Medical worth $618K as of Q1 2026.
  • Daiwa Securities Group bought 575 Globus Medical shares in Q1 2026, an estimated $51.6K.
  • Globus Medical made up ﹤0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #866 holding.
  • Daiwa Securities Group first reported a position in Globus Medical in Q3 2023 and has held it in 8 quarters since.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.